Objective: The lifespan of people with schizophrenia is shortened compared to the general
population. We reviewed the literature on comorbid physical diseases in schizophrenia to …

These updated guidelines are based on the first edition of the World Federation of Societies
of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia …

Decisions about the use of psychotropic medication in pregnancy are an ongoing challenge
for clinicians and women with mental health problems, owing to the uncertainties around …

OBJECTIVE: This study ascertained the incidence of complications during pregnancy, labor,
and delivery and the neonatal characteristics of infants born to women with schizophrenia …

Background The loss of a child is considered one of the most stressful events in the life of a
parent. We hypothesized that parental bereavement increases the risk of hospital admission …

Research on infectious agents as a possible cause of schizophrenia has become prominent
in the past decade. Toxoplasma gondii has emerged as a prime candidate for a variety of …

OBJECTIVE: The aim of this article is to offer recommendations and rationale for gender-
specific antipsychotic treatment. METHOD: The author summarizes reviews of recent …

A range of complications of pregnancy, abnormal fetal growth and development, and
complications of delivery have been associated with increased risk of schizophrenia. Few …

The effect of various antipsychotics during pregnancy has repeatedly been studied, but for
most atypical antipsychotics, only little information is available. We identified from the …

It is now well established that obstetric complications or obstetric events increase the risk for
schizophrenia. This is a small effect—the pooled odds ratio of the effect of exposure to …